Neonatal Abstinence Syndrome – webinar

September 11, 2017
September 19, 2017: Neonatal Abstinence Syndrome: What is it and how can it be prevented?
Tuesday, September 19, 2017 12:30:00 PM EDT – 1:30:00 PM EDT

Every 25 minutes, a baby is born suffering from opioid withdrawal. Maternal opioid use and neonatal abstinence syndrome (NAS) is dramatically increasing, by nearly five-fold since 2000, providing newborns with greater likelihood of birthweight, respiratory complications, and other critical health conditions. (NIH, 2017).  This webinar will describe, review screening and treatment recommendations, and showcase select health programs for managing NAS. 

Dr. Joseph El Khoury, Assistant Professor in the Division of Neonatal-Perinatal Medicine at the Children’s Hospital of Richmond at Virginia Commonwealth University (VCU).
The CT Birth to Three System includes Neonatal Abstinence Syndrome on the list of established conditions that confer automatic eligibility when referred within 3 months due to the high likelihood of these infants experiencing developmental delay.

Not finding what you're looking for?

Search Birth to Three